Exane Derivatives’s Rapid7 RPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$41.1K Hold
616
0.02% 326
2022
Q1
$68.5K Buy
616
+612
+15,300% +$61.5K 0.02% 528
2021
Q4
$471 Sell
4
-1,184
-100% -$146K ﹤0.01% 773
2021
Q3
$134K Hold
1,188
0.03% 487
2021
Q2
$122K Sell
1,188
-268
-18% -$22.6K 0.03% 517
2021
Q1
$109K Buy
1,456
+1,006
+224% +$83.6K 0.03% 412
2020
Q4
$40.6K Sell
450
-1,089
-71% -$77.9K 0.01% 473
2020
Q3
$94.2K Sell
1,539
-348
-18% -$20.7K 0.03% 305
2020
Q2
$96.3K Sell
1,887
-3,626
-66% -$169K 0.03% 299
2020
Q1
$239K Sell
5,513
-2,065
-27% -$108K 0.07% 178
2019
Q4
$472K Buy
+7,578
New +$394K 0.09% 173

Other funds holding RPD

Exane Derivatives's RPD Position: Q2 2022 in Review

Exane Derivatives held its Rapid7 (RPD) position steady in Q2 2022 at 616 shares worth $41.1K. The position accounts for 0.02% of the portfolio, ranked #326.

Exane Derivatives first reported a position in RPD in Q4 2019 and has held it in 11 quarters since. The position peaked at $472K in Q4 2019. 305 funds tracked by Wall St. Rank hold RPD as of Q2 2022.

  • Exane Derivatives held 616 shares of Rapid7 worth $41.1K as of Q2 2022.
  • Exane Derivatives left its Rapid7 share count unchanged in Q2 2022.
  • Rapid7 made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #326 holding.
  • Exane Derivatives first reported a position in Rapid7 in Q4 2019 and has held it in 11 quarters since.
  • Exane Derivatives's Rapid7 position peaked at $472K in Q4 2019.
  • 305 funds tracked by Wall St. Rank held Rapid7 as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.